T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTB
2426
HomeTrust Bancshares
HTB
$866M
| $523K | ﹤0.01% |
12,244
+3,061
| +33% | +$132K |
|
2427
Arbutus Biopharma
ABUS
$847M
| $522K | ﹤0.01% |
115,990
+26,774
| +30% | +$117K |
|
2428
Talkspace
TALK
$874M
| $522K | ﹤0.01% |
100,683
+16,442
| +20% | +$72.8K |
|
2429
ArriVent BioPharma
AVBP
$1.4B
| $522K | ﹤0.01% |
22,593
+6,478
| +40% | +$146K |
|
2430
Bowman Consulting
BWMN
$454M
| $519K | ﹤0.01% |
18,216
+1,336
| +8% | +$43.5K |
|
2431
Orion
OEC
$403M
| $519K | ﹤0.01% |
79,702
+6,769
| +9% | +$40.1K |
|
2432
Sharplink Inc
SBET
$1.29B
| $519K | ﹤0.01% |
80,385
+5,600
| +7% | +$45.3K |
|
2433
Orrstown Financial Services
ORRF
$850M
| $517K | ﹤0.01% |
14,323
+3,636
| +34% | +$132K |
|
2434
SELLAS Life Sciences
SLS
$1.99B
| $517K | ﹤0.01% |
122,120
+59,094
| +94% | +$264K |
|
|
BKV
2435
BKV Corp
BKV
$2.55B
| $516K | ﹤0.01% |
18,075
+6,178
| +52% | +$179K |
|
2436
Bloomin' Brands
BLMN
$754M
| $514K | ﹤0.01% |
95,021
+11,257
| +13% | +$72.1K |
|
2437
Willis Lease Finance
WLFC
$1.65B
| $514K | ﹤0.01% |
9,051
+477
| +6% | +$28.7K |
|
2438
QuinStreet
QNST
$927M
| $513K | ﹤0.01% |
42,682
+11,575
| +37% | +$147K |
|
|
OS
2439
DELISTED
OneStream Inc
OS
| $513K | ﹤0.01% |
21,355
+1,500
| +8% | +$35.2K |
|
2440
UroGen Pharma
URGN
$1.97B
| $512K | ﹤0.01% |
28,454
-588,152
| -95% | -$11.8M |
|
2441
FRP Holdings
FRPH
$439M
| $510K | ﹤0.01% |
23,268
+1,615
| +7% | +$37.6K |
|
2442
State Street Technology Select Sector SPDR ETF
XLK
$109B
| $509K | ﹤0.01% |
3,824
| – | – |
|
2443
Nu Skin
NUS
$257M
| $508K | ﹤0.01% |
69,693
+5,712
| +9% | +$51.7K |
|
2444
Keros Therapeutics
KROS
$197M
| $507K | ﹤0.01% |
45,876
+16,177
| +54% | +$250K |
|
2445
Vanguard Total Stock Market ETF
VTI
$646B
| $503K | ﹤0.01% |
1,565
| – | – |
|
2446
Lindblad Expeditions
LIND
$1.95B
| $502K | ﹤0.01% |
28,962
+6,455
| +29% | +$115K |
|
2447
Teekay
TK
$996M
| $502K | ﹤0.01% |
41,080
+9,929
| +32% | +$110K |
|
2448
Janus International
JBI
$702M
| $501K | ﹤0.01% |
97,255
+19,695
| +25% | +$127K |
|
2449
uniQure
QURE
$2.75B
| $498K | ﹤0.01% |
30,447
-178,199
| -85% | -$3.61M |
|
2450
AdvanSix
ASIX
$542M
| $497K | ﹤0.01% |
20,333
+4,512
| +29% | +$85.2K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.